Yan Paccaud Gerald Berthet Annette Von Scheven-Gête Bernard Vaudaux Yvan Mivelaz Michael Hofer Matthias Roth-Kleiner
10.1186/1546-0096-12-52
Pediatr Rheumatol Online J
2014 Dec 15;12:52.
anakinra cinca il-1 receptor il-1β nomid neonatal treatment
CC BY
https://pubmed.ncbi.nlm.nih.gov/25584041/
Antirheumatic Agents / therapeutic use Cryopyrin-Associated Periodic Syndromes / drug therapy Interleukin 1 Receptor Antagonist Protein / therapeutic use Interleukin-1 / antagonists & inhibitors
Antirheumatic Agents / therapeutic use Cryopyrin-Associated Periodic Syndromes / drug therapy Interleukin 1 Receptor Antagonist Protein / therapeutic use Interleukin-1 / antagonists & inhibitors Case Reports Carrier Proteins / genetics Cryopyrin-Associated Periodic Syndromes / diagnosis Cryopyrin-Associated Periodic Syndromes / genetics Female Humans Infant, Newborn Infant, Premature Male Mutation / genetics NLR Family, Pyrin Domain-Containing 3 Protein Time Factors Treatment Outcome Antirheumatic Agents Carrier Proteins Interleukin 1 Receptor Antagonist Protein Interleukin-1 NLR Family, Pyrin Domain-Containing 3 Protein NLRP3 protein, human
PMC4290099
25584041
Neonatal treatment of CINCA syndrome
2014